Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

19 Oct 2020 11:06

RNS Number : 4854C
Midatech Pharma PLC
19 October 2020
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMGZMMGGLKGGZM
Date   Source Headline
20th Dec 20177:00 amRNSMidatech initiates Gelclair Phase IV trial
22nd Nov 20177:00 amRNSMidatech receives manufacturing certification
7th Nov 20179:35 amRNSIssue of Equity for Midatech Share Incentive Plan
19th Oct 201710:52 amRNSHolding(s) in Company
19th Oct 20179:44 amRNSHoldings in Company
16th Oct 201712:44 pmRNSResult of General Meeting
28th Sep 20172:35 pmRNSResult of Placing to raise £6m & PDMR Shareholding
28th Sep 20177:01 amRNSInterim Results 2017
28th Sep 20177:00 amRNSProposed Placing and Open Offer
21st Sep 20179:00 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSNotice of interim results
4th Sep 20177:00 amRNSMidatech submits MTD201 CTA filing
25th Aug 20171:59 pmRNSHolding(s) in Company
26th Jul 20177:00 amRNSCompletion of pre-clinical liver cancer programme
18th Jul 20177:00 amRNSTrading Update and Notice of Results
13th Jun 20177:00 amRNSSite visit for investors and analysts
7th Jun 20177:00 amRNSMidatech signs global agreement for panobinostat
22nd May 20177:00 amRNSProgress update on brain cancer therapies
19th May 20173:12 pmRNSIssue of Equity for Midatech Share Incentive Plan
3rd May 20172:30 pmRNSResult of AGM
4th Apr 20177:02 amRNSFinancial results for year ended 31 December 2016
14th Mar 20177:00 amRNSNotice of Results
10th Mar 20177:00 amRNSMidatech Announces Initial Scale-Up of Facility
27th Feb 20177:00 amRNSMidatech enters into Loan Agreement with SVB
20th Jan 201711:05 amRNSSecond Price Monitoring Extn
20th Jan 201711:00 amRNSPrice Monitoring Extension
20th Jan 20177:00 amRNSTrading Update
20th Dec 201612:56 pmRNSDirector/PDMR Shareholding
15th Dec 20164:31 pmRNSHolding(s) in Company
22nd Nov 20167:00 amRNSMidatech receives upfront on Emergex vaccine deal
15th Nov 20167:00 amRNSMidatech selects MTR104 for liver cancer treatment
2nd Nov 201612:57 pmRNSHolding(s) in Company
2nd Nov 20169:51 amRNSHolding(s) in Company
28th Oct 201611:12 amRNSResult of GM, Open Offer & Issue of Equity
11th Oct 20162:59 pmRNSResults of Placing to raise £16.0 million
11th Oct 201611:18 amRNSProposed Placing and Open Offer
30th Sep 20167:00 amRNSFirst in Human Immunotherapy Study Start
21st Sep 20167:00 amRNSMidatech Pharma US Partnership with R-Pharm US
2nd Sep 20167:00 amRNSInterim Results
10th Aug 20167:00 amRNSTrading Update and Notice of Results
7th Jul 20168:15 amRNSMidatech receives grant funding
30th Jun 20161:11 pmRNSAnnual Report Posting
27th Jun 20167:00 amRNSIssue of Equity and Director's Dealings
18th May 20167:00 amRNSMidatech Pharma announces clinical pipeline update
11th May 20165:28 pmRNSResult of AGM
11th May 20167:00 amRNSAGM Statement and Update on Trading
26th Apr 20167:00 amRNSMidatech announces positive Q-Octreotide data
21st Apr 20167:00 amRNSPositive data for OpsiSporin Uveitis programme
13th Apr 20167:00 amRNSFinancial results for the year ended 31 Dec 2015
11th Apr 20167:00 amRNSCommercial Launch of Zuplenz® (Ondansetron) in US

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.